Study Group: Tarceva Prescribers for Non-Small Cell Lung Cancer (US)(?)
Council Members in this Study Group: 48
Request a survey with this Study Group
Leading Experts in this Study Group
Donald Fleming, MDDivision Head of Hematology and Oncology
Davis Health System, Inc.
Donald Fleming, MD, is the Head of Hematology-Oncology at the Medical Center of Vincennes. Previously, Dr. Fleming was a Tenured Professor in the Division of Hematology-Oncology at University of Louisville. He has published over 25 manuscripts in peer-reviewed journals and remains involved in clinical...
Consultant
Medical Consulting Firm of Dr. Ben Ebrahimi
Ben Ebrahimi, MD, is Director of Clinical Trials at Wilshire Oncology Medical Group. Dr. Ebrahimi oversees clinical trials in various tumor types and treats a variety of cancer patients including lung, breast, colorectal, and lymphomas. These clinical trials include biological agents as well as targeted...
Haitham Al-Okk, MDAssistant Clinical Professor - Hematology-Oncology
Mahr Cancer Center
Haitham Al-Okk, MD, is a Specialist in Hematology-Oncology at Graves-Gilbert Cancer Clinic, a multi-specialty medical group in Kentucky. Dr. Al-Okk is board certified in Internal Medicine and Medical Oncology, and fellowship trained in Hematology-Oncology. He specializes in lung, breast, and colorectal...
Professor & Deputy Director of Cancer Institute
THE PENNSYLVANIA STATE UNIVERSITY
Chandra Belani, MD, is a Distinguished Professor of Medicine in the Division of Hematology-Oncology at the Penn State College of Medicine. He is also a Deputy Director of the Penn State Cancer Institute. Dr. Belani's major research interest is lung cancer, including drug development, chemoprevention,...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Bcl-2 inhibition by small molecules stands to be the next avenue for antineoplastic therapy- Looks like the real deal!
No reason for the increased mortality vs Chemo alone was identified. Cell Genesys is looking into where to go now.
Velcade + classic Melphalan/ Prednisone (MP) is better than MP alone. No surprise
Chronic ITP is not all that uncommon and becomes a quality of life issue with chronic steroid use as well as agents that are normaly used in neoplasia and even derivatives of male hormones.
Advanced Cell Technology in Worcester, Mass., the University of Illinois at Chicago and the Mayo Clinic in Rochester, Minn. scientists say they've found an efficient way to make red blood cells from human embryonic stem cells. Impreesive!
Most Common Company Types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- Medical Director
- Consultant
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

